Security key
48576U106
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)
CUSIP: 48576U106
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 22,658,403
- Total 13F shares
- 63,829,194
- Share change
- -3,915,618
- Total reported value
- $988,058,899
- Put/Call ratio
- 70%
- Price per share
- $15.48
- Number of holders
- 165
- Value change
- -$54,468,075
- Number of buys
- 82
- Number of sells
- 64
Report period
Q4 2020
Institutions
165
Top holders
10
KPTI full security history
Newer quarter: Q1 2021
Previous quarter: Q3 2020
Karyopharm Therapeutics Inc. SEC filings
Karyopharm Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48576U106
Recent filing periods:
Top shareholders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
32%
|
7,169,789
|
$104,679,000 | — | 30 Sep 2020 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
26%
|
6,000,000
|
$87,600,000 | — | 30 Sep 2020 | |
| Palo Alto Investors LP |
13F
|
Company |
22%
|
5,086,152
|
$74,258,000 | — | 30 Sep 2020 | |
| STATE STREET CORP |
13F
|
Company |
21%
|
4,788,974
|
$69,919,000 | — | 30 Sep 2020 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
16%
|
3,703,786
|
$54,075,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
15%
|
3,444,065
|
$50,284,000 | — | 30 Sep 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
14%
|
3,212,931
|
$46,909,000 | — | 30 Sep 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
11%
|
2,387,470
|
$34,857,000 | — | 30 Sep 2020 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.6%
|
2,164,900
|
$31,608,000 | — | 30 Sep 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
7.7%
|
1,742,700
|
$25,443,000 | — | 30 Sep 2020 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
7.1%
|
1,603,253
|
$23,407,000 | — | 30 Sep 2020 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
6.4%
|
1,455,222
|
$21,246,000 | — | 30 Sep 2020 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
6.4%
|
1,449,517
|
$21,163,000 | — | 30 Sep 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
6.3%
|
1,437,011
|
$20,980,000 | — | 30 Sep 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
5.7%
|
1,287,652
|
$18,800,000 | — | 30 Sep 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
5.2%
|
1,185,900
|
$17,314,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.7%
|
1,055,335
|
$15,407,000 | — | 30 Sep 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
4.6%
|
1,052,236
|
$15,363,000 | — | 30 Sep 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
4.1%
|
927,438
|
$13,541,000 | — | 30 Sep 2020 | |
| Hood River Capital Management LLC |
13F
|
Company |
4%
|
915,760
|
$13,370,000 | — | 30 Sep 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
3.8%
|
864,678
|
$12,624,000 | — | 30 Sep 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
3.8%
|
851,707
|
$12,435,000 | — | 30 Sep 2020 | |
| Fairmount Funds Management LLC |
13F
|
Company |
3.1%
|
702,351
|
$10,254,000 | — | 30 Sep 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
3.1%
|
697,608
|
$10,185,000 | — | 30 Sep 2020 | |
| AMI ASSET MANAGEMENT CORP |
13F
|
Company |
2.7%
|
612,962
|
$8,949,000 | — | 30 Sep 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
2.3%
|
523,370
|
$7,641,000 | — | 30 Sep 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
2.3%
|
515,909
|
$7,533,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
435,578
|
$6,359,000 | — | 30 Sep 2020 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.7%
|
381,332
|
$5,567,000 | — | 30 Sep 2020 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.5%
|
349,723
|
$5,106,000 | — | 30 Sep 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.5%
|
346,513
|
$5,059,000 | — | 30 Sep 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.4%
|
318,985
|
$4,653,000 | — | 30 Sep 2020 | |
| Granahan Investment Management, LLC |
13F
|
Company |
1.2%
|
267,697
|
$3,908,000 | — | 30 Sep 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1%
|
230,889
|
$3,371,000 | — | 30 Sep 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1%
|
226,435
|
$3,306,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0.9%
|
203,619
|
$2,973,000 | — | 30 Sep 2020 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.86%
|
194,817
|
$2,844,000 | — | 30 Sep 2020 | |
| J. Goldman & Co LP |
13F
|
Company |
0.8%
|
181,904
|
$2,656,000 | — | 30 Sep 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.79%
|
179,818
|
$2,625,000 | — | 30 Sep 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.79%
|
179,008
|
$2,614,000 | — | 30 Sep 2020 | |
| FMR LLC |
13F
|
Company |
0.78%
|
177,010
|
$2,584,000 | — | 30 Sep 2020 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.77%
|
175,000
|
$2,555,000 | — | 30 Sep 2020 | |
| Phocas Financial Corp. |
13F
|
Company |
0.75%
|
169,525
|
$2,475,000 | — | 30 Sep 2020 | |
| Birchview Capital, LP |
13F
|
Company |
0.74%
|
168,000
|
$2,453,000 | — | 30 Sep 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.73%
|
164,973
|
$2,409,000 | — | 30 Sep 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.7%
|
159,227
|
$2,325,000 | — | 30 Sep 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.7%
|
158,523
|
$2,314,000 | — | 30 Sep 2020 | |
| Laurion Capital Management LP |
13F
|
Company |
0.66%
|
149,752
|
$2,186,000 | — | 30 Sep 2020 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.62%
|
139,729
|
$2,040,000 | — | 30 Sep 2020 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.61%
|
138,176
|
$2,017,000 | — | 30 Sep 2020 |
Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q4 2020
As of 31 Dec 2020,
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by
165 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,829,194 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, Palo Alto Investors LP, VANGUARD GROUP INC, FRONTIER CAPITAL MANAGEMENT CO LLC, ALKEON CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Delphi Management Partners VIII, L.L.C., and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
165
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
155
Q4 2020 holders
165
Holder diff
10
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.